# SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study

> **NCT07515820** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Meng Qiu** · enrollment: 12 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** SHR-3821 and fruquintinib

## Key facts

- **NCT ID:** NCT07515820
- **Lead sponsor:** Meng Qiu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-27
- **Primary completion:** 2027-07-28
- **Final completion:** 2028-04-28
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515820, "SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07515820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*